Prediction of Metabolic Interactions With Oxycodone via CYP2D6 and CYP3A Inhibition Using a Physiologically Based Pharmacokinetic Model

Evaluation of a potential risk of metabolic drug–drug interactions (DDI) is of high importance in the clinical setting. In this study, a physiologically based pharmacokinetic (PBPK) model was developed for oxycodone and its two primary metabolites, oxymorphone and noroxycodone, in order to assess di...

Descripción completa

Detalles Bibliográficos
Autores principales: Marsousi, N, Daali, Y, Rudaz, S, Almond, L, Humphries, H, Desmeules, J, Samer, C F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288002/
https://www.ncbi.nlm.nih.gov/pubmed/25518025
http://dx.doi.org/10.1038/psp.2014.49

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288002/
https://www.ncbi.nlm.nih.gov/pubmed/25518025
http://dx.doi.org/10.1038/psp.2014.49

Ejemplares similares